185 related articles for article (PubMed ID: 22414449)
1. Editorial. PSA screening and low risk prostate cancer, what's going on? are we shooting the messenger?
MartÃnez-Salamanca JI
Arch Esp Urol; 2012 Mar; 65(2):209-14. PubMed ID: 22414449
[No Abstract] [Full Text] [Related]
2. [PSA-based screening for prostatic cancer].
Johansen TE
Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3550. PubMed ID: 10563168
[No Abstract] [Full Text] [Related]
3. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
4. Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens.
Berger AP; Spranger R; Kofler K; Steiner H; Bartsch G; Horninger W
Prostate; 2003 Oct; 57(2):93-8. PubMed ID: 12949932
[TBL] [Abstract][Full Text] [Related]
5. Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment.
Soloway MS; Soloway CT; Eldefrawy A; Acosta K; Kava B; Manoharan M
Eur Urol; 2010 Dec; 58(6):831-5. PubMed ID: 20800964
[TBL] [Abstract][Full Text] [Related]
6. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857
[TBL] [Abstract][Full Text] [Related]
7. Further support for active surveillance in the management of low-volume, low-grade prostate cancer.
Albertsen P
Eur Urol; 2010 Dec; 58(6):836-7. PubMed ID: 20851512
[No Abstract] [Full Text] [Related]
8. What's a doctor to do? Helping patients decide about prostate cancer screening.
Katz A; Sisler JJ
Can Fam Physician; 2004 Jan; 50():14-6, 22-4. PubMed ID: 14761096
[No Abstract] [Full Text] [Related]
9. The Japanese guideline for prostate cancer screening.
Hamashima C; Nakayama T; Sagawa M; Saito H; Sobue T
Jpn J Clin Oncol; 2009 Jun; 39(6):339-51. PubMed ID: 19346535
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.
Khatami A; Hugosson J; Wang W; Damber JE
Scand J Urol Nephrol; 2009; 43(1):12-8. PubMed ID: 18949633
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of prostate-specific antigen as a screening test for prostate cancer.
Dorr VJ; Williamson SK; Stephens RL
Arch Intern Med; 1993 Nov; 153(22):2529-37. PubMed ID: 7694555
[TBL] [Abstract][Full Text] [Related]
12. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
[TBL] [Abstract][Full Text] [Related]
13. Using PSA to screen for prostate cancer. The Washington University experience.
Andriole GL; Catalona WJ
Urol Clin North Am; 1993 Nov; 20(4):647-51. PubMed ID: 7505972
[TBL] [Abstract][Full Text] [Related]
14. [Prostate cancer and prostate specific antigen screening].
Camici M
Minerva Med; 2004 Feb; 95(1):25-34. PubMed ID: 15041924
[TBL] [Abstract][Full Text] [Related]
15. Screening for prostate cancer: who and how often?
Schwartz K; Deschere B; Xu J
J Fam Pract; 2005 Jul; 54(7):586-96. PubMed ID: 16009085
[TBL] [Abstract][Full Text] [Related]
16. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base.
Freedland SJ; Kane CJ; Presti JC; Terris MK; Amling CL; Dorey F; Aronson WJ
J Urol; 2003 Mar; 169(3):969-73. PubMed ID: 12576824
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer trends in southeast Michigan 1973-1992.
Demers RY
In Vivo; 1994; 8(3):429-31. PubMed ID: 7528558
[TBL] [Abstract][Full Text] [Related]
18. The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience.
Smith DS; Humphrey PA; Catalona WJ
Cancer; 1997 Nov; 80(9):1852-6. PubMed ID: 9351559
[TBL] [Abstract][Full Text] [Related]
19. Using predictive value, sensitivity and specificity to interpret laboratory tests: PSA for the diagnosis of prostate cancer.
Ashley T
J Insur Med; 2005; 37(4):261-3. PubMed ID: 16459948
[TBL] [Abstract][Full Text] [Related]
20. What's new in prostate cancer screening and prevention?
Klein EA
Cleve Clin J Med; 2009 Aug; 76(8):439-45. PubMed ID: 19652036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
